LivaNova
Yahoo Finance • 5 hours ago
Apple initiated, DraftKings downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Jefferies upgraded Carvana (CVNA) to B... Full story
Yahoo Finance • last month
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
LONDON, August 22, 2025--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and Alex Shvartsburg, Chief Financial Officer, will pres... Full story
Yahoo Finance • 2 months ago
Jefferies Maintained a Buy Rating on LivaNova PLC (LIVN)
LivaNova PLC (NASDAQ:LIVN) is one of the Best Undervalued UK Stocks to Buy According to Analysts. On June 6, Jefferies analyst Matthew Taylor maintained a Buy rating on LivaNova PLC (NASDAQ:LIVN) with a price target of $79. The analyst hi... Full story
Yahoo Finance • 3 months ago
Interesting LIVN Put And Call Options For September 19th
Investors in LivaNova PLC (Symbol: LIVN) saw new options become available today, for the September 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LIVN options chain for the new September 19th... Full story
Yahoo Finance • 4 months ago
LivaNova's SWOT analysis: medical device firm's stock faces growth hurdles
LivaNova PLC (NASDAQ:LIVN), a global medical technology company specializing in cardiopulmonary and neuromodulation products with a market capitalization of $2.5 billion, stands at a critical juncture as it navigates a complex landscape o... Full story
Yahoo Finance • 7 months ago
LivaNova PLC Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
It's been a mediocre week for LivaNova PLC (NASDAQ:LIVN) shareholders, with the stock dropping 15% to US$40.93 in the week since its latest annual results. Revenues were US$1.3b, approximately in line with whatthe analysts expected, althou... Full story
Yahoo Finance • 12 months ago
LivaNova PLC (LIVN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Revenue: $319 million, an increase of 10% versus 2023. Cardiopulmonary Segment Revenue: $174 million, an increase of 14% versus Q2 2023. Heart-Lung Machine Revenue: Increased over 25% driven by Essenz. Oxygenator Revenue: Grew more than 15... Full story
Yahoo Finance • 2 years ago
LivaNova PLC (NASDAQ:LIVN) Q4 2023 Earnings Call Transcript
LivaNova PLC (NASDAQ:LIVN) Q4 2023 Earnings Call Transcript February 21, 2024 LivaNova PLC beats earnings expectations. Reported EPS is $0.87, expectations were $0.79. LIVN isn't one of the 30 most popular stocks among hedge funds at the... Full story
Yahoo Finance • 2 years ago
LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
William Kozy will remain Board Chair LONDON, February 05, 2024--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced its Board of Directors named Vladimir A. Makatsaria as the Company’... Full story
Yahoo Finance • 2 years ago
LivaNova Reports Third-Quarter 2023 Results
LONDON, November 01, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended September 30, 2023 and raised full-year 2023 revenue and adjusted diluted ea... Full story
Yahoo Finance • 2 years ago
Is LivaNova PLC (LIVN) a Good Value Stock?
The London Company, an investment management company, released “The London Company Small Cap Strategy” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund returned 7.7% gross (7.5%... Full story
Yahoo Finance • 2 years ago
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
Mechelen, Belgium;15June 2023,22:01 CET;regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced the appointment of Thad Huston as Chief Financial Officer (CFO) and Chief Operating Officer (COO) as per 1 July 2023. Mr... Full story
Yahoo Finance • 2 years ago
Galapagos benoemt Thad Huston tot Chief Financial Officer en Chief Operating Officer
Mechelen, België;15 juni 2023,22:01 CET;gereglementeerde informatie - Galapagos NV (Euronext & NASDAQ: GLPG) kondigde vandaag de benoeming aan van Thad Huston als Chief Financial Officer (CFO) en Chief Operating Officer (COO) per 1 juli 20... Full story
Yahoo Finance • 2 years ago
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical Study
LONDON, June 13, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the 150th bipolar depression patient has been randomized in the RECOVER clinical study, "A Pro... Full story
Yahoo Finance • 2 years ago
David Einhorn’s 2023 Portfolio: Top 15 Stock Picks
In this piece, we will take a look at the top 15 stock picks of David Einhorn's 2023 portfolio. For more stock picks, head on over to David Einhorn's 2023 Portfolio: Top 5 Stock Picks. After the unexpected beating that investors and the s... Full story
Yahoo Finance • 3 years ago
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
LONDON, March 09, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lu... Full story
Yahoo Finance • 3 years ago
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
LONDON, February 08, 2023--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*. The release h... Full story
